Multiple protein-protein interactions converging on the Prp38 protein during activation of the human spliceosome
- RNA. 2016 Feb;22(2):265-77. doi: 10.1261/rna.054296.115.
- 1. Freie Universität Berlin, Laboratory of Structural Biochemistry, D-14195 Berlin, Germany.
- 2. Max-Planck Institute for Molecular Genetics, Otto-Warburg Laboratory, D-14195 Berlin, Germany.
- 3. Max Planck Institute for Biophysical Chemistry, Department of Cellular Biochemistry, D-37077 Göttingen, Germany.
- 4. Max-Planck Institute for Molecular Genetics, Otto-Warburg Laboratory, D-14195 Berlin, Germany University of Graz, Institute of Pharmaceutical Sciences (IPW), Pharmaceutical Chemistry, A-8010 Graz, Austria.
Spliceosomal Prp38 proteins contain a conserved amino-terminal domain, but only higher eukaryotic orthologs also harbor a carboxy-terminal RS domain, a hallmark of splicing regulatory SR proteins. We show by crystal structure analysis that the amino-terminal domain of human Prp38 is organized around three pairs of antiparallel α-helices and lacks similarities to RNA-binding domains found in canonical SR proteins. Instead, yeast two-hybrid analyses suggest that the amino-terminal domain is a versatile protein-protein interaction hub that possibly binds 12 Other spliceosomal proteins, most of which are recruited at the same stage as Prp38. By quantitative, alanine surface-scanning two-hybrid screens and biochemical analyses we delineated four distinct interfaces on the Prp38 amino-terminal domain. In vitro interaction assays using recombinant proteins showed that Prp38 can bind at least two proteins simultaneously via two different interfaces. Addition of excess Prp38 amino-terminal domain to in vitro splicing assays, but not of an interaction-deficient mutant, stalled splicing at a precatalytic stage. Our results show that human Prp38 is an unusual SR protein, whose amino-terminal domain is a multi-interface protein-protein interaction platform that might organize the relative positioning of Other proteins during splicing.